Trials / Completed
CompletedNCT02755467
Clinical Evaluation of the Treatment of Spider Angioma
A Clinical Evaluation of the Treatment of Spider Angioma Using a Dual Wavelength Laser Emitting 532 nm Laser Energy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Cutera Inc. · Industry
- Sex
- All
- Age
- 5 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the safety and effectiveness of the laser treatment for the treatment of spider angiomas.
Detailed description
The purpose of this study is to evaluate the safety and efficacy of the 532 nm KTP laser within the Cutera Excel V system for the treatment of spider angiomas.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | KTP laser | Dual Wavelength Laser Emitting 532 nm Laser Energy |
Timeline
- Start date
- 2016-05-26
- Primary completion
- 2017-01-13
- Completion
- 2017-04-04
- First posted
- 2016-04-29
- Last updated
- 2023-03-24
- Results posted
- 2023-03-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02755467. Inclusion in this directory is not an endorsement.